Prescriber, operator, purchaser, payer and patient — separate incentives — feline ckd subcutaneous fluid therapy

1. Summary

The domain dossier's §3 already lays out the five-role table from its one owner-practice survey (Cooley et al., PMID 28948902) and names three open gaps: no source separates veterinary-technician incentives from veterinarian incentives, no source addresses clinic-side economics of supplying fluids, and no source measures the purchaser role in dollar terms. This report does not close those gaps outright — no device-specific or fluid-therapy-specific literature for any of them was found — but it adds two feline-CKD-specific surveys not previously mined for user-group content (an owner caregiver-burden survey and a practitioner-management survey, both distinct from the dossier's Cooley source), plus general small-animal-practice economics literature on financial-limitation distress, technician turnover costs, online price opacity, and insurance-driven spending behavior. None of it is subcutaneous-fluid-therapy-specific; every line below rests on exactly one source and carries that marker.

2. What Changed

_Baseline (v1). No prior version; this establishes the starting point for future diffs._

3. Details

Prescriber — guideline awareness is high, but owner constraints already limit what gets done

A 2023 questionnaire study of 409 veterinary practitioners in Portugal found that although 92.7% (379/409) reported using IRIS guidelines to manage feline CKD, only 35.7% (146/409) were actually able to comply with the guideline-recommended 2-3-month (or more frequent) recheck interval for stable patients, "due to owners' constraints" — the study's own stated reason [single-source] [1]. The same study found systolic blood pressure was measured systematically in only 19.1% (78/409) of patients despite near-universal guideline awareness [single-source] [1]. This is a direct, feline-CKD-specific instance of the pattern the dossier's §3 already flags qualitatively (a guideline-endorsed intervention constrained by something other than the guideline itself) but is drawn from a different, non-US population (Portugal) and is not evidence about the specific subcutaneous-fluid-therapy recommendation.

A 2017 JAVMA cross-sectional survey of 1,122 US and Canadian small-animal practitioners (37,036 surveyed) found 57% (620/1,088) reported client economic limitations affected their ability to provide desired care on a daily basis, and 49% (527/1,071) reported moderate-to-substantial burnout, with economic limitations cited as a contributing factor [single-source] [2]. This is general small-animal-practice economics, not CKD- or fluid-therapy-specific, offered as the closest US-based measure of how a prescriber's recommendation environment is already shaped by a client's ability to pay.

Operator — the veterinary technician carries training load and distress the dossier's gap names but cannot yet quantify for this domain

The dossier's §2 records that in-clinic owner training for home fluid administration is typically performed by "veterinarian/technician." A 2025 JAVMA survey of 207 emergency veterinarians and 154 emergency veterinary technicians in the US found nearly 95% of veterinarian respondents reported seeing owner-reported financial limitations affecting patient care at least weekly, and reported that technicians expressed distress about being unable to provide recommended care more often than veterinarians did [single-source] [3]. This is emergency-practice-specific, not chronic-disease-management-specific, but it is the only source located this pass that separates a technician's experience from a veterinarian's at all — a partial, directional answer to the dossier's own named gap, not a resolution of it. A separate 2026 JAVMA paper states plainly that "workforce shortages and turnover among credentialed veterinary technicians impose substantial operational and financial costs on veterinary practices" and that "veterinary technician-specific transition-to-practice research remains limited" [single-source] [4], which bears on whether the technician workforce that currently performs owner training for home fluid administration is a stable one; no quantified turnover rate specific to feline-CKD or fluid-therapy training was located.

Purchaser — a price-opaque channel, not fluid-therapy-specific

A 2026 cross-sectional study of 177 US small-animal veterinary clinics (157 with a website) found only 3 (1.91%) published specific service pricing online, only 7 (4.46%) offered a "Wellness Plan," and only 2 (1.27%) mentioned insurance options on their sites [single-source] [5]. This does not report fluid-supply or implant-kit pricing specifically — it is general small-animal pricing opacity — but it bears directly on the dossier's own named gap that no source measures the purchaser role in dollar terms: an owner in this domain has, per this study, a low probability of finding a price for anything before a treatment decision is made, whatever the item.

Payer — still functionally absent; where insurance exists, it changes spending

Consistent with the dossier's own §6 finding that no federal or near-universal private payer for veterinary devices exists, the only payer-adjacent evidence located this pass concerns private pet insurance uptake and its effect on spending, not coverage of subcutaneous fluid therapy specifically. A 2021 US choice-experiment survey of 306 uninsured dog owners found insurance uptake increased 12.3% after treatment-cost and disease-risk information was presented, and 44% of respondents were willing to spend up to $1,000 and 46% were willing to spend $3,000 or more to prolong their pet's life by a year [single-source] [6]. A 2020 US logit-model study of dog owners found pet health insurance "had a significant and positive impact on the amount spent at the veterinarian" [single-source] [7]. Both studies surveyed dog owners, not cat owners, and neither addresses CKD or fluid therapy; they are offered as the closest available evidence that insurance status, where present, changes spending behavior in the same US companion-animal market this domain sits in.

Patient (cat) and the person acting on its behalf — a feline-CKD-specific caregiver-burden survey

A 2025 survey of 100 UK owners of cats with CKD found 99% reported feelings of anxiety associated with caring for their cat, 66% said their daily routine had changed a lot since diagnosis, and 37% said caring for their cat negatively impacted or restricted their own life [single-source] [8]. The same survey found extreme worry, anxiety or concern related to prognosis was reported by 72% of owners at diagnosis and 50% at survey completion, and the authors described owners as "reported experiencing feelings of anxiety associated with caring for their cat, suggesting caregiver burden," calling for "veterinary professionals, including veterinary nurses" to play a greater role in education and support to alleviate it [8]. This survey did not ask specifically about subcutaneous fluid administration as distinct from CKD management generally, and its sample is UK, not US; it is the single most direct piece of published evidence in this domain that the "operator" role (whether owner or technician) carries a burden the guideline-content sections of the dossier do not capture.

4. Sources

[1] "Clinical management of feline chronic kidney disease in Portugal: a questionnaire-based study" — Journal of Feline Medicine and Surgery (published 2023, month not given in the PubMed record; accessed 2026-09-01). PMID 37987623 — https://pubmed.ncbi.nlm.nih.gov/37987623/ [peer-reviewed]

[2] "Factors that influence small animal veterinarians' opinions and actions regarding cost of care and effects of economic limitations on patient care and outcome and professional career satisfaction and burnout" — Journal of the American Veterinary Medical Association (published 2017, month not given in the PubMed record; accessed 2026-09-01). PMID 28306486 — https://pubmed.ncbi.nlm.nih.gov/28306486/ [peer-reviewed]

[3] "Owner-reported financial limitations negatively impact emergency veterinary teams" — Journal of the American Veterinary Medical Association (published 2025-12-01; accessed 2026-09-01). PMID 41052540 — https://pubmed.ncbi.nlm.nih.gov/41052540/ [peer-reviewed]

[4] "Beyond the 'sink-or-swim' training mentality: can structured onboarding improve veterinary technician satisfaction and retention?" — Journal of the American Veterinary Medical Association (published 2026-09-01 per the PubMed record; accessed 2026-09-01). PMID 41999735 — https://pubmed.ncbi.nlm.nih.gov/41999735/ [peer-reviewed]

[5] "Lack of online price transparency of small animal veterinary clinics in the United States" — Frontiers in Veterinary Science (published 2026, month not given in the PubMed record; accessed 2026-09-01). PMID 42158322 — https://pubmed.ncbi.nlm.nih.gov/42158322/ [peer-reviewed]

[6] "Analysis of the demand for pet insurance among uninsured pet owners in the United States" — The Veterinary Record (published 2021-07, day not given in the PubMed record; accessed 2026-09-01). PMID 33870521 — https://pubmed.ncbi.nlm.nih.gov/33870521/ [peer-reviewed]

[7] "The Impact of Pet Health Insurance on Dog Owners' Spending for Veterinary Services" — Animals (published 2020-07-09; accessed 2026-09-01). PMID 32659934 — https://pubmed.ncbi.nlm.nih.gov/32659934/ [peer-reviewed]

[8] "Owners' experiences of caring for cats with chronic kidney disease in the UK" — Journal of Feline Medicine and Surgery (published 2025, month not given in the PubMed record; accessed 2026-09-01). PMID 40235283 — https://pubmed.ncbi.nlm.nih.gov/40235283/ [peer-reviewed]

5. Sourcing & Gaps

Well established: Nothing in this report rests on ≥2 independent, non-affiliated primary sources agreeing on the same specific quantity — every line above is a single finding from a single source, marked [single-source] throughout §3. The structural fact that no federal or near-universal private veterinary payer exists is not re-derived here; it is the dossier's own §6 finding (sourced there to 21 CFR 807.65(b)) and is only referenced by this report, not re-established.

Thin: All eight sources are [single-source] findings, none upgraded to plain fact regardless of how authoritative any one source is. Only two ([1], [8]) are feline-CKD-specific; the remaining six are general small-animal-practice economics applied by analogy, and none of the eight addresses subcutaneous fluid therapy, needle-based administration, or any implanted access device directly — the operator/purchaser/payer content the dossier's §3 already names as missing remains largely missing after this pass, narrowed rather than closed.

Rescoped from class 3: No class-3 question was posed or answered in this report. The dossier's own §9 already records and rescopes the two class-3 questions relevant to this domain (would owners choose an implanted port; would general-practice veterinarians place one) to their revealed-behaviour twins in its §5, and this report does not repeat or re-litigate that work.

Out of scope: CPT descriptors and veterinary claims/EHR/payer datasets were not attempted, consistent with this domain's own manifest marking reimbursement and market-players out-of-scope-licensed. A PatentsView-backed patent search was not attempted (credential unset, and immaterial to user-group incentives specifically).

Not searched vs. not found: A 2026 NAPHIA "State of the Industry" report figure (cat-specific US pet-insurance penetration, cited in secondary press coverage as 2.29%) was located by WebSearch but not used — the retrievable document (a PDF at naphia.org) carries no PMID, DOI, CFR, NCT, K-number, HCPCS code, CELEX number, or FR Doc number, and per this repo's sourcing rule a URL alone is not a resolvable identifier; it is named here as seen and deliberately not cited, not as an oversight. A feline- or CKD-specific study of technician incentives, clinic-side fluid/supply markup, or owner cost specifically for subcutaneous fluid administration was searched for directly (connectors literature, multiple query variants including "veterinary technician client education subcutaneous fluid cats," "financial constraints veterinary care decision cats chronic disease," "veterinary nurse client communication chronic kidney disease cat," and "subcutaneous fluid therapy cost home clinic cats owner") and returned zero PubMed records for each — recorded as found-and-negative for those specific queries, not as unsearched. aaha.org and avma.org were not re-attempted this pass; the dossier and a sibling domain's report already record both as returning bot-mitigation blocks in this environment.

[inference] None. This report contains no synthesis beyond what each cited source states.

6. Claim Candidates